We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Highly Sensitive Mass Spectrometry Methods for Quantifying PROTACs

Drug manufacturing machinery
Credit: iStock

Protein-targeting chimeras (PROTACs) have gained significant attention recently due to their high potency in nanomolar drug concentrations and target selectivity. However, low test concentrations in complex matrices present analytical challenges. 

To ensure safety and efficancy in the drug development pipline, highly sensitive and selective assays are necessary. This application note presents a new assay for the quantification of sub-nanomolar levels of PROTACS in a complex matrix using mass spectrometry, for accurate and sensitive analysis during drug development. 


Download this application note to discover how you can: 

  • Minimize sample volume and sample preparation time
  • Achieve robust analytical performance
  •  Easily meet regulatory guidelines with compliance-ready software

Brought to you by

Access this App Note for FREE Now!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.